{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:56:00Z","timestamp":1794567360813,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K12EY016335"],"award-info":[{"award-number":["K12EY016335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["1K23EY035342"],"award-info":[{"award-number":["1K23EY035342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58686-6","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:19:25Z","timestamp":1746271165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-5149","authenticated-orcid":false,"given":"Joel T.","family":"R\u00e4m\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-4672","authenticated-orcid":false,"given":"Bryan R.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Chen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1605-9782","authenticated-orcid":false,"given":"Sean J.","family":"Jurgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panisa","family":"Singhanetr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa G.","family":"Tieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon HC","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Halladay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-8970","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake M.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-6988","authenticated-orcid":false,"given":"Soo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2649-8199","authenticated-orcid":false,"given":"Joost","family":"Brinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FinnGen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VA Million Veteran Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-3762","authenticated-orcid":false,"given":"Saiju","family":"Pyarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-2743","authenticated-orcid":false,"given":"Cari L.","family":"Nealon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-7982","authenticated-orcid":false,"given":"Michael B.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2834-2024","authenticated-orcid":false,"given":"Wen-Chih","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Roncone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaarniranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Yzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-5874","authenticated-orcid":false,"given":"Aarno","family":"Palotie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4419-7226","authenticated-orcid":false,"given":"Neal S.","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-9146","authenticated-orcid":false,"given":"Joni A.","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel JF","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7488-250X","authenticated-orcid":false,"given":"Sudha K.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-9575","authenticated-orcid":false,"given":"Elizabeth J.","family":"Rossin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"58686_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann, A. S., Pulido, J. S., Diehl, N. N., Hodge, D. O. & Burke, J. P. The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology 115, 169\u2013173 (2008).","journal-title":"Ophthalmology"},{"key":"58686_CR2","unstructured":"Feenstra H. M. A. et al. Central serous chorioretinopathy: An evidence-based treatment guideline. Prog Retin Eye Res. 101236 (2024)."},{"key":"58686_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen, T. J. et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog. Retin Eye Res 73, 100770 (2019).","journal-title":"Prog. Retin Eye Res"},{"key":"58686_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3126\/nepjoph.v11i1.25410","volume":"11","author":"NK Sahoo","year":"2019","unstructured":"Sahoo, N. K. et al. Prevalence and Profile of Central Serous Chorioretinopathy in an Indian Cohort. Nepal J. Ophthalmol. 11, 5\u201310 (2019).","journal-title":"Nepal J. Ophthalmol."},{"key":"58686_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/bjo.2004.049403","volume":"89","author":"JA Montero","year":"2005","unstructured":"Montero, J. A. Ruiz-Moreno JM. Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy. Br. J. Ophthalmol. 89, 562\u2013564 (2005).","journal-title":"Br. J. Ophthalmol."},{"key":"58686_CR6","doi-asserted-by":"publisher","first-page":"CR51","DOI":"10.12659\/MSM.882455","volume":"18","author":"U Gajdzik-Gajdecka","year":"2012","unstructured":"Gajdzik-Gajdecka, U. et al. Indocyanine green angiography in chronic central serous chorioretinopathy. Med Sci. Monit. 18, CR51\u2013CR57 (2012).","journal-title":"Med Sci. Monit."},{"key":"58686_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1080\/02713683.2016.1276196","volume":"42","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli, I. et al. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study. Curr. Eye Res 42, 1069\u20131073 (2017).","journal-title":"Curr. Eye Res"},{"key":"58686_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide, R. F. et al. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders. Prog. Retin Eye Res 86, 100973 (2022).","journal-title":"Prog. Retin Eye Res"},{"key":"58686_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.113.008331","volume":"130","author":"G Piazza","year":"2014","unstructured":"Piazza, G. Varicose veins. Circulation 130, 582\u2013587 (2014).","journal-title":"Circulation"},{"key":"58686_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","volume":"136","author":"RL Schellevis","year":"2018","unstructured":"Schellevis, R. L. et al. Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study. JAMA Ophthalmol. 136, 1128\u20131136 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"58686_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s42003-019-0712-z","volume":"2","author":"Y Hosoda","year":"2019","unstructured":"Hosoda, Y. et al. Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Commun. Biol. 2, 468 (2019).","journal-title":"Commun. Biol."},{"key":"58686_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaophthalmol.2023.0706","volume":"141","author":"JT R\u00e4m\u00f6","year":"2023","unstructured":"R\u00e4m\u00f6, J. T. et al. Overlap of genetic loci for central serous chorioretinopathy with age-related macular degeneration. JAMA Ophthalmol. 141, 449\u2013457 (2023).","journal-title":"JAMA Ophthalmol."},{"key":"58686_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ophtha.2014.09.026","volume":"122","author":"EK de Jong","year":"2015","unstructured":"de Jong, E. K. et al. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology 122, 562\u2013570 (2015).","journal-title":"Ophthalmology"},{"key":"58686_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100955","volume":"84","author":"EHC van Dijk","year":"2021","unstructured":"van Dijk, E. H. C. & Boon, C. J. F. Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula. Prog. Retin Eye Res 84, 100955 (2021).","journal-title":"Prog. Retin Eye Res"},{"key":"58686_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.576","volume":"7","author":"RL Schellevis","year":"2019","unstructured":"Schellevis, R. L. et al. Exome sequencing in families with chronic central serous chorioretinopathy. Mol. Genet Genom. Med 7, e00576 (2019).","journal-title":"Mol. Genet Genom. Med"},{"key":"58686_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton, A. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"58686_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"58686_CR18","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.ophtha.2016.04.025","volume":"123","author":"PA Campochiaro","year":"2016","unstructured":"Campochiaro, P. A. et al. Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression. Ophthalmology 123, 1722\u20131730 (2016).","journal-title":"Ophthalmology"},{"key":"58686_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49990-8","volume":"15","author":"I Manipur","year":"2024","unstructured":"Manipur, I. et al. CoPheScan: phenome-wide association studies accounting for linkage disequilibrium. Nat. Commun. 15, 5862 (2024).","journal-title":"Nat. Commun."},{"key":"58686_CR20","doi-asserted-by":"publisher","first-page":"24100","DOI":"10.1073\/pnas.1914143116","volume":"116","author":"AP Voigt","year":"2019","unstructured":"Voigt, A. P. et al. Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc. Natl Acad. Sci. USA 116, 24100\u201324107 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58686_CR21","doi-asserted-by":"publisher","unstructured":"Voigt A. P. et al. Single-Cell RNA Sequencing in Human Retinal Degeneration Reveals Distinct Glial Cell Populations. Cells. https:\/\/doi.org\/10.3390\/cells9020438 (2020).","DOI":"10.3390\/cells9020438"},{"key":"58686_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2020.104031","volume":"131","author":"AP Voigt","year":"2020","unstructured":"Voigt, A. P. et al. Bulk and single-cell gene expression analyses reveal aging human choriocapillaris has pro-inflammatory phenotype. Microvasc. Res 131, 104031 (2020).","journal-title":"Microvasc. Res"},{"key":"58686_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108204","volume":"200","author":"AP Voigt","year":"2020","unstructured":"Voigt, A. P. et al. Spectacle: An interactive resource for ocular single-cell RNA sequencing data analysis. Exp. Eye Res 200, 108204 (2020).","journal-title":"Exp. Eye Res"},{"key":"58686_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1210\/clinem\/dgab670","volume":"107","author":"J Brinks","year":"2022","unstructured":"Brinks, J. et al. The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy. J. Clin. Endocrinol. Metab. 107, 512\u2013524 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"58686_CR25","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1093\/emboj\/cdf497","volume":"21","author":"R Nawroth","year":"2002","unstructured":"Nawroth, R. et al. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 21, 4885\u20134895 (2002).","journal-title":"EMBO J."},{"key":"58686_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"58686_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1126\/science.aav5095","volume":"364","author":"GD Gaiha","year":"2019","unstructured":"Gaiha, G. D. et al. Structural topology defines protective CD8+ T cell epitopes in the HIV proteome. Science 364, 480\u2013484 (2019).","journal-title":"Science"},{"key":"58686_CR28","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1016\/j.cell.2021.06.029","volume":"184","author":"A Nathan","year":"2021","unstructured":"Nathan, A. et al. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell 184, 4401\u20134413.e10 (2021).","journal-title":"Cell"},{"key":"58686_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41525-024-00416-w","volume":"9","author":"BM Hauser","year":"2024","unstructured":"Hauser, B. M. et al. Structure-based network analysis predicts pathogenic variants in human proteins associated with inherited retinal disease. NPJ Genom. Med 9, 31 (2024).","journal-title":"NPJ Genom. Med"},{"key":"58686_CR30","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1182\/blood-2006-01-0141","volume":"107","author":"S B\u00e4umer","year":"2006","unstructured":"B\u00e4umer, S. et al. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107, 4754\u20134762 (2006).","journal-title":"Blood"},{"key":"58686_CR31","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1073\/pnas.0611510104","volume":"104","author":"MG Dominguez","year":"2007","unstructured":"Dominguez, M. G. et al. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc. Natl Acad. Sci. USA 104, 3243\u20133248 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58686_CR32","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1038\/sj.onc.1202992","volume":"18","author":"G Fachinger","year":"1999","unstructured":"Fachinger, G., Deutsch, U. & Risau, W. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18, 5948\u20135953 (1999).","journal-title":"Oncogene"},{"key":"58686_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/humu.22551","volume":"35","author":"C Schubert","year":"2014","unstructured":"Schubert, C. et al. Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy. Hum. Mutat. 35, 859\u2013867 (2014).","journal-title":"Hum. Mutat."},{"key":"58686_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35188-3","volume":"13","author":"XR Gao","year":"2022","unstructured":"Gao, X. R., Chiariglione, M. & Arch, A. J. Whole-exome sequencing study identifies rare variants and genes associated with intraocular pressure and glaucoma. Nat. Commun. 13, 7376 (2022).","journal-title":"Nat. Commun."},{"key":"58686_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"58686_CR36","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1172\/JCI85830","volume":"126","author":"T Souma","year":"2016","unstructured":"Souma, T. et al. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J. Clin. Invest 126, 2575\u20132587 (2016).","journal-title":"J. Clin. Invest"},{"key":"58686_CR37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0092-8674(00)81814-0","volume":"87","author":"M Vikkula","year":"1996","unstructured":"Vikkula, M. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87, 1181\u20131190 (1996).","journal-title":"Cell"},{"key":"58686_CR38","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","volume":"125","author":"E Boscolo","year":"2015","unstructured":"Boscolo, E. et al. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J. Clin. Invest 125, 3491\u20133504 (2015).","journal-title":"J. Clin. Invest"},{"key":"58686_CR39","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1172\/JCI95545","volume":"127","author":"BR Thomson","year":"2017","unstructured":"Thomson, B. R. et al. Angiopoietin-1 is required for Schlemm\u2019s canal development in mice and humans. J. Clin. Invest 127, 4421\u20134436 (2017).","journal-title":"J. Clin. Invest"},{"key":"58686_CR40","doi-asserted-by":"publisher","unstructured":"Chu M., et al. Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII. Elife. https:\/\/doi.org\/10.7554\/eLife.21032 (2016).","DOI":"10.7554\/eLife.21032"},{"key":"58686_CR41","doi-asserted-by":"publisher","unstructured":"Karska-Basta I., et al. Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy. J. Clin. Med. Res. https:\/\/doi.org\/10.3390\/jcm10051087 (2021).","DOI":"10.3390\/jcm10051087"},{"key":"58686_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ajo.2024.08.040","volume":"269","author":"JT R\u00e4m\u00f6","year":"2024","unstructured":"R\u00e4m\u00f6, J. T. et al. Targeting the Tie-2 receptor with faricimab in central serous chorioretinopathy: A case series motivated by a genetic finding. Am. J. Ophthalmol. 269, 246\u2013254 (2024).","journal-title":"Am. J. Ophthalmol."},{"key":"58686_CR43","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1172\/JCI74527","volume":"124","author":"J Shen","year":"2014","unstructured":"Shen, J. et al. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J. Clin. Invest 124, 4564\u20134576 (2014).","journal-title":"J. Clin. Invest"},{"key":"58686_CR44","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1084\/jem.20150718","volume":"212","author":"M Frye","year":"2015","unstructured":"Frye, M. et al. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin. J. Exp. Med 212, 2267\u20132287 (2015).","journal-title":"J. Exp. Med"},{"key":"58686_CR45","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847046","volume":"20","author":"LJ Braun","year":"2019","unstructured":"Braun, L. J. et al. VE-PTP inhibition stabilizes endothelial junctions by activating FGD5. EMBO Rep. 20, e47046 (2019).","journal-title":"EMBO Rep."},{"key":"58686_CR46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","volume":"36","author":"P Kanda","year":"2022","unstructured":"Kanda, P. et al. Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye 36, 941\u2013962 (2022).","journal-title":"Eye"},{"key":"58686_CR47","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1172\/JCI77162","volume":"124","author":"BR Thomson","year":"2014","unstructured":"Thomson, B. R. et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J. Clin. Invest 124, 4320\u20134324 (2014).","journal-title":"J. Clin. Invest"},{"key":"58686_CR48","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1172\/JCI94668","volume":"127","author":"J Kim","year":"2017","unstructured":"Kim, J. et al. Impaired angiopoietin\/Tie2 signaling compromises Schlemm\u2019s canal integrity and induces glaucoma. J. Clin. Invest 127, 3877\u20133896 (2017).","journal-title":"J. Clin. Invest"},{"key":"58686_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.61.14.12","volume":"61","author":"G Li","year":"2020","unstructured":"Li, G. et al. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm\u2019s Canal Increasing Outflow Facility and Reducing Intraocular Pressure. Invest Ophthalmol. Vis. Sci. 61, 12 (2020).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"58686_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.11.1.7","volume":"11","author":"M Brigell","year":"2022","unstructured":"Brigell, M., Withers, B., Buch, A. & Peters, K. G. Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension. Transl. Vis. Sci. Technol. 11, 7 (2022).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"58686_CR51","doi-asserted-by":"publisher","first-page":"e1008682","DOI":"10.1371\/journal.pgen.1008682","volume":"16","author":"Y Tanigawa","year":"2020","unstructured":"Tanigawa, Y. et al. Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma. PLoS Genet 16, e1008682 (2020).","journal-title":"PLoS Genet"},{"key":"58686_CR52","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41588-023-01428-5","volume":"55","author":"X Han","year":"2023","unstructured":"Han, X. et al. Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci. Nat. Genet 55, 1116\u20131125 (2023).","journal-title":"Nat. Genet"},{"key":"58686_CR53","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.2921","volume":"46","author":"S Behjati","year":"2014","unstructured":"Behjati, S. et al. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat. Genet 46, 376\u2013379 (2014).","journal-title":"Nat. Genet"},{"key":"58686_CR54","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jnci\/djt164","volume":"105","author":"S Goel","year":"2013","unstructured":"Goel, S. et al. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J. Natl Cancer Inst. 105, 1188\u20131201 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"58686_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CJI.0000000000000290","volume":"42","author":"G Li","year":"2019","unstructured":"Li, G., Sachdev, U., Peters, K., Liang, X. & Lotze, M. T. The VE-PTP Inhibitor AKB\u22129778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration. J. Immunother. 42, 237\u2013243 (2019).","journal-title":"J. Immunother."},{"key":"58686_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-022-00618-w","volume":"22","author":"SM Stanford","year":"2023","unstructured":"Stanford, S. M. & Bottini, N. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders. Nat. Rev. Drug Discov. 22, 273\u2013294 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58686_CR57","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res"},{"key":"58686_CR58","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","volume":"5","author":"GH Lyman","year":"2021","unstructured":"Lyman, G. H. et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 5, 927\u2013974 (2021).","journal-title":"Blood Adv."},{"key":"58686_CR59","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","volume":"70","author":"JM Gaziano","year":"2016","unstructured":"Gaziano, J. M. et al. Million Veteran Program: A mega-biobank to study genetic influences on health and disease. J. Clin. Epidemiol. 70, 214\u2013223 (2016).","journal-title":"J. Clin. Epidemiol."},{"key":"58686_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajhg.2020.03.004","volume":"106","author":"H Hunter-Zinck","year":"2020","unstructured":"Hunter-Zinck, H. et al. Genotyping array design and data quality control in the Million Veteran Program. Am. J. Hum. Genet 106, 535\u2013548 (2020).","journal-title":"Am. J. Hum. Genet"},{"key":"58686_CR61","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"JC Denny","year":"2019","unstructured":"All of Us Research Program Investigators, Denny, J. C. et al. The \u201cAll of Us\u201d Research Program. N. Engl. J. Med 381, 668\u2013676 (2019).","journal-title":"N. Engl. J. Med"},{"key":"58686_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"58686_CR63","doi-asserted-by":"publisher","first-page":"e0164095","DOI":"10.1371\/journal.pone.0164095","volume":"11","author":"PA Keane","year":"2016","unstructured":"Keane, P. A. et al. Optical Coherence Tomography in the UK Biobank Study - Rapid Automated Analysis of Retinal Thickness for Large Population-Based Studies. PLoS One 11, e0164095 (2016).","journal-title":"PLoS One"},{"key":"58686_CR64","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet"},{"key":"58686_CR65","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajhg.2017.08.012","volume":"101","author":"C Benner","year":"2017","unstructured":"Benner, C. et al. Prospects of Fine-Mapping Trait-Associated Genomic Regions by Using Summary Statistics from Genome-wide Association Studies. Am. J. Hum. Genet 101, 539\u2013551 (2017).","journal-title":"Am. J. Hum. Genet"},{"key":"58686_CR66","doi-asserted-by":"publisher","first-page":"e1010299","DOI":"10.1371\/journal.pgen.1010299","volume":"18","author":"Y Zou","year":"2022","unstructured":"Zou, Y., Carbonetto, P., Wang, G. & Stephens, M. Fine-mapping from summary data with the \u201cSum of Single Effects\u201d model. PLoS Genet 18, e1010299 (2022).","journal-title":"PLoS Genet"},{"key":"58686_CR67","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet 50, 1335\u20131341 (2018).","journal-title":"Nat. Genet"},{"key":"58686_CR68","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ajhg.2019.08.012","volume":"105","author":"H Fang","year":"2019","unstructured":"Fang, H. et al. Harmonizing genetic ancestry and self-identified race\/ethnicity in genome-wide association studies. Am. J. Hum. Genet 105, 763\u2013772 (2019).","journal-title":"Am. J. Hum. Genet"},{"key":"58686_CR69","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1093\/bioinformatics\/btab186","volume":"37","author":"AP Boughton","year":"2021","unstructured":"Boughton, A. P. et al. LocusZoom.js: interactive and embeddable visualization of genetic association study results. Bioinformatics 37, 3017\u20133018 (2021).","journal-title":"Bioinformatics"},{"key":"58686_CR70","doi-asserted-by":"publisher","first-page":"eadj1182","DOI":"10.1126\/science.adj1182","volume":"385","author":"A Verma","year":"2024","unstructured":"Verma, A. et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science 385, eadj1182 (2024).","journal-title":"Science"},{"key":"58686_CR71","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/bioinformatics\/btq126","volume":"26","author":"JC Denny","year":"2010","unstructured":"Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205\u20131210 (2010).","journal-title":"Bioinformatics"},{"key":"58686_CR72","unstructured":"PyMOL [Internet]. 2020 [cited 2024 Sep 1]. Available from: http:\/\/www.pymol.org\/pymol"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58686-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T12:03:26Z","timestamp":1746273806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58686"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58686-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Rossin and Dr. R\u00e4m\u00f6 are named inventors on a provisional patent application that describes the secondary use of intravitreal Anti-Ang2 medications for use in the treatment of central serous chorioretinopathy. Dr. Ellinor receives sponsored research support from Bayer AG, IBM Research, Bristol Myers Squibb, Pfizer and Novo Nordisk; he has also served on advisory boards or consulted for MyoKardia and Bayer AG. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4127"}}